Kufril LS Plus Expectorant is a combination syrup formulated to provide effective relief from respiratory conditions characterized by cough and mucus congestion. Each 5ml dose contains Ambroxol 30mg, Levosalbutamol 1mg, and Guaifenesin 50mg, working synergistically to alleviate symptoms associated with bronchial disorders. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, thereby improving airway patency. Levosalbutamol, a selective β2-adrenergic receptor agonist, provides bronchodilation by relaxing bronchial smooth muscles, which helps reduce bronchospasm and ease breathing. Guaifenesin serves as an expectorant, promoting the thinning and loosening of mucus, making it easier to cough up and clear from the airways. Kufril LS Plus is indicated for the symptomatic treatment of productive cough in conditions such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). The combination of these active ingredients ensures comprehensive management of cough and mucus-related respiratory symptoms. It is recommended to use Kufril LS Plus under medical supervision, with dosage adjusted according to patient age and clinical condition. Caution is advised in patients with hypersensitivity to any component, cardiovascular disorders, or hyperthyroidism.